SEC Comment Letter 0000000000-25-003738 to Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc.
Date: April 8, 2025 · CIK: 0001782303 · Accession: 0000000000-25-003738
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286302
Letter
Re: Boundless Bio, Inc. Registration Statement on Form S-3 Filed April 1, 2025 File No. 333-286302 Dear Zachary Hornby:
April 8, 2025
Zachary Hornby Chief Executive Officer Boundless Bio, Inc. 10955 Alexandria Way, Suite 100 San Diego, CA 92121
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Cheston Larson
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 8, 2025 Zachary Hornby Chief Executive Officer Boundless Bio, Inc. 10955 Alexandria Way, Suite 100 San Diego, CA 92121 Re: Boundless Bio, Inc. Registration Statement on Form S-3 Filed April 1, 2025 File No. 333-286302 Dear Zachary Hornby: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Cheston Larson </TEXT> </DOCUMENT>